NEW YORK (GenomeWeb News) – Roche said this morning that it will dissolve its Applied Science Business Area by the end of this year and integrate products from that business with other parts of its Diagnostics Business Area.

As part of the reorganization, Roche said that it will cut around 110 positions in Penzberg, Germany and 60 positions in Branford, Conn., which is the home of its 454 Life Sciences business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.